Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression
M Mendes, AC Monteiro, E Neto, CC Barrias… - International Journal of …, 2024 - mdpi.com
Acute myeloid leukaemia (AML) management remains a significant challenge in oncology
due to its low survival rates and high post-treatment relapse rates, mainly attributed to …
due to its low survival rates and high post-treatment relapse rates, mainly attributed to …
Cancer Stem Cells from Definition to Detection and Targeted Drugs
B Ruszkowska-Ciastek, K Kwiatkowska… - International Journal of …, 2024 - mdpi.com
Cancers remain the second leading cause of mortality in the world. Preclinical and clinical
studies point an important role of cancer/leukaemia stem cells (CSCs/LSCs) in the …
studies point an important role of cancer/leukaemia stem cells (CSCs/LSCs) in the …
Identification of cells of leukemic stem cell origin with non-canonical regenerative properties
Despite most acute myeloid leukemia (AML) patients entering remission following
chemotherapy, outcomes remain poor due to surviving leukemic cells that contribute to …
chemotherapy, outcomes remain poor due to surviving leukemic cells that contribute to …
Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome them
SQ Li, M Chen, XY Huang, H Wang… - Expert Review of …, 2023 - Taylor & Francis
Introduction Minimal residual disease (MRD) has been an important biomarker for relapse
prediction and treatment choice in patients with acute myeloid leukemia (AML). False …
prediction and treatment choice in patients with acute myeloid leukemia (AML). False …
[引用][C] DEVELOPMENT OF A PROGNOSTIC INDICATOR FOR CURATIVE HEMATOPOIETIC STEM CELL TRANSPLANT REQUIREMENTS IN ACUTE MYELOID …
S Murali - 2023